Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2003
12/11/2003WO2003080566A3 Hif hydroxylase inhibitors
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003044053A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
12/11/2003WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003026579A3 Combination therapies for immune mediated diseases
12/11/2003WO2003024958A3 Processes for the preparation of 1,5-diaryl-3-substituted-pyrazoles
12/11/2003WO2003024926A3 Methods and compositions of novel triazine compounds
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption
12/11/2003WO2003011895A8 Compositions and methods for modulation of immune responses
12/11/2003WO2003011226A3 Products and drug delivery vehicles
12/11/2003WO2003004460A3 Succinic acid derivatives
12/11/2003WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds
12/11/2003WO2002094273A3 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/11/2003WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003WO2002083071A3 Heterocyclic analgesic compounds and methods of use thereof
12/11/2003WO2002053149A3 Medicament containing a polyamine as an active substance
12/11/2003US20030229231 Forming chelate compounds
12/11/2003US20030229226 Cathepsin cysteine protease inhibitors
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/11/2003US20030229145 Analgesics; amino acid drug
12/11/2003US20030229116 Enamine derivatives
12/11/2003US20030229110 Cell signal transduction
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229090 Controlling activation of mast cells; antiallergens; antiinflamamtory agents
12/11/2003US20030229088 Novel methods and compositions for alleviating pain
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
12/11/2003US20030229076 Therapy for psychological disorders; cardiovascular disorders; antidiabetic agents; central nervous system disorders
12/11/2003US20030229075 Induce immunology response; genetic engineering; gene expression; crystallization
12/11/2003US20030229067 Sedative, vasodilation, antiarrhythmia agents, antiallergens, antiinflammatory agents
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229064 Method of treating cancer using dithiocarbamate derivatives
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229048 Skin disorders; antiinflammatory agents
12/11/2003US20030229047 Liquid formulation of decitabine and use of the same
12/11/2003US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
12/11/2003US20030228662 Comprises nucleotide sequences coding tetrodoxin resistant transport protein for diagnosing, prevention and treatment of pain, muscular and cardiac disorders
12/11/2003US20030228625 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
12/11/2003US20030228568 Inducible phosphofructokinase and the warburg effect
12/11/2003US20030228365 Pharmaceutical formulation
12/11/2003US20030228359 Antiallergen mixture
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003US20030228257 Induction apoptosis; antiarthritic agents
12/11/2003CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003CA2487688A1 Piperidine derivative, process for producing the same, and use
12/11/2003CA2487679A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003CA2487509A1 New salts
12/11/2003CA2484451A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369491A1 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/10/2003EP1369421A1 Pharmaceutical compositions comprising 2,3-Diaryl-pyrazolo[1,5-B]pyridazine derivatives
12/10/2003EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
12/10/2003EP1369417A1 Acridine derivatives
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1368660A2 Assay
12/10/2003EP1368648A2 Detection of compounds that modulate inflammatory responses
12/10/2003EP1368473A2 Neurotransmission-associated proteins
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
12/10/2003EP1368343A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
12/10/2003EP1368341A1 Phenyl derivatives 3
12/10/2003EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors
12/10/2003EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368318A2 Calcilytic compounds
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators
12/10/2003EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP1368306A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368036A1 Regulation of glucocorticoid concentration
12/10/2003EP1368031A2 Method of treating of demyelinating diseases or conditions
12/10/2003EP1368024A1 Treatment of restenosis
12/10/2003EP1368018A2 Use of sugar phosphate, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycolysis-enzyme complex, the malate-aspartate shuttle and/or transaminases
12/10/2003EP1368016A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
12/10/2003EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
12/10/2003EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability
12/10/2003EP1368003A1 Methods and compositions for reducing the taste of pharmaceutically active agents
1 ... 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 ... 1272